New & Updated

Here is a list of recently added titles to Bookshelf and updated books and releases

Recent Releases

Alirocumab -- Addendum to Commission A15-47 [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 Apr 14.

Systematic Guideline Search and Appraisal, as Well as Extraction of Relevant Recommendations, for a DMP "Osteoporosis" [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 Apr 1.

Newborn Screening for Critical Congenital Heart Disease Using Pulse Oximetry [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Mar 11.

Insulin Degludec / Liraglutide (Addendum to Commission A15-15) [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Sep 24.

Safinamide (Addendum to Commission A15-18) [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Nov 5.

Fingolimod: Benefit Assessment According to §35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Jun 29.

Aclidinium Bromide -- Benefit Assessment According to §35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 Jan 12.

Rilpivirine (New Therapeutic Indication) -- Addendum to Commission A15-55 [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 May 25.

Alirocumab -- Benefit Assessment According to §35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 Feb 11.

Crizotinib (New Therapeutic Indication) -- Benefit Assessment According to §35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 Mar 30.

View More Recent Releases

Insulin Degludec (Addendum to Commission A15-10) [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Aug 7.

Systematic Guideline Search and Appraisal, as Well as Extraction of Relevant Recommendations, for a DMP "Chronic Back Pain" [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Nov 18.

Mepolizumab -- Benefit Assessment According to §35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 Apr 28.

Netupitant / Palonosetron -- Benefit Assessment According to §35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Nov 12.

Secukinumab (Addendum to Commission A15-20) [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Oct 28.

Regorafenib -- Benefit Assessment According to §35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Dec 23.

How can voluntary cross-border collaboration in public procurement improve access to health technologies in Europe? [Internet].

Espín J, Rovira J, Calleja Aet al., authors; Richardson E, Palm W, Richardson E, et al., editors.

Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2016. (Policy Brief, No. 21.)

Investing in health literacy: What do we know about the co-benefits to the education sector of actions targeted at children and young people? [Internet].

McDaid D, author; Richardson E, Wismar M, Palm W, et al., editors.

Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2016. (Policy Brief, No. 19.)

Lomitapide (Addendum to Commission A15-23) [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Dec 3.

A randomised placebo-controlled Phase III multicentre trial: low-dose intravenous immunoglobulin treatment for long-standing complex regional pain syndrome (LIPS trial).

Goebel A, Bisla J, Carganillo R, et al.

Southampton (UK): NIHR Journals Library; 2017 Nov. (Efficacy and Mechanism Evaluation, No. 4.5.)

Umeclidinium -- Benefit Assessment According to §35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 Apr 28.

Regorafenib -- Addendum to Commission A15-43 [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 Feb 26.

European Observatory Policy Brief Series.

Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2013-.

Ibrutinib -- Benefit Assessment According to §35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016 Apr 28.

Trametinib -- Benefit Assessment According to §35a Social Code Book V [Internet].

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Dec 28.

Updated

BEST (Biomarkers, EndpointS, and other Tools) Resource [Internet].

FDA-NIH Biomarker Working Group.

Silver Spring (MD): Food and Drug Administration (US); Bethesda (MD): National Institutes of Health (US); 2016-.

Validation (Added 11-14-2017)
Validated Surrogate Endpoint (Added 09-25-2017)

PDQ Cancer Information Summaries [Internet].

Bethesda (MD): National Cancer Institute (US); 2002-.

Mistletoe Extracts (PDQ®) (Added 11-15-2017)
View More Updates
Breast Cancer Treatment (PDQ®) (Added 11-07-2017)
Depression (PDQ®) (Added 11-07-2017)
Acupuncture (PDQ®) (Added 11-01-2017)
Medicinal Mushrooms (PDQ®) (Added 11-01-2017)
Ewing Sarcoma Treatment (PDQ®) (Added 11-01-2017)
Genetics of Skin Cancer (PDQ®) (Added 10-25-2017)
Acupuncture (PDQ®) (Added 10-25-2017)
Vulvar Cancer Treatment (PDQ®) (Added 10-18-2017)
Breast Cancer Treatment (PDQ®) (Added 10-18-2017)
Neuroblastoma Treatment (PDQ®) (Added 10-10-2017)
Breast Cancer Screening (PDQ®) (Added 10-10-2017)
Medicinal Mushrooms (PDQ®) (Added 10-10-2017)
Skin Cancer Screening (PDQ®) (Added 10-03-2017)
Lung Cancer Screening (PDQ®) (Added 10-03-2017)
Neuroblastoma Treatment (PDQ®) (Added 10-03-2017)
Ewing Sarcoma Treatment (PDQ®) (Added 09-26-2017)
Depression (PDQ®) (Added 09-13-2017)
Cancer Pain (PDQ®) (Added 09-06-2017)
Cancer Pain (PDQ®) (Added 09-06-2017)
Skin Cancer Treatment (PDQ®) (Added 09-06-2017)
Lung Cancer Prevention (PDQ®) (Added 09-06-2017)
Colon Cancer Treatment (PDQ®) (Added 08-30-2017)
Melanoma Treatment (PDQ®) (Added 08-30-2017)
Hydrazine Sulfate (PDQ®) (Added 08-22-2017)
Breast Cancer Screening (PDQ®) (Added 08-22-2017)

Informed Health Online [Internet].

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-.

Atrial fibrillation: Overview (Added 11-02-2017)
View More Updates
Treating acute bronchitis (Added 10-03-2017)
Acute bronchitis: Overview (Added 10-03-2017)
Falls in older people: Overview (Added 09-06-2017)
Medication for quitting smoking (Added 09-06-2017)

Statistical Brief (Medical Expenditure Panel Survey (US)) [Internet].

Rockville (MD): Agency for Healthcare Research and Quality (US); 2001-.

GeneReviews® [Internet].

Adam MP, Ardinger HH, Pagon RA, et al., editors.

Seattle (WA): University of Washington, Seattle; 1993-2017.

Disorders of GNAS Inactivation (Added 10-26-2017)
Poikiloderma with Neutropenia (Added 10-26-2017)
SATB2-Associated Syndrome (Added 10-12-2017)
Ethylmalonic Encephalopathy (Added 09-21-2017)
UNC80 Deficiency (Added 09-21-2017)
Potocki-Lupski Syndrome (Added 08-24-2017)

Recent Activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...